Pacific Biosciences of California PACB Available-for-Sale Debt Securities - Fair Value (Maturing Within 1 Year)

Available-for-Sale Debt Securities - Fair Value (Maturing Within 1 Year) at other companies

ACNBACNB

$399K—

Heritage FinancialHFWA

$0—

Peapack-Gladstone FinancialPGC

$14.92M—

Capital City Bank GroupCCBG

$58.45M-76.2%

Independent Bank CorporationIBCP

$15.49M+34.0%

Banner CorporationBANR

$7.41M+112%

Other financials

Income statement

See full

Revenue$37.2M+0.1%

Gross profit$12.8M+1,037%

Operating income-$8.4M+98.1%

Net income-$8.3M+98.1%

EPS (diluted)-$0.03+97.9%

Balance sheet

See full

Cash & equivalents$57.9M-4.7%

Total debt$59.3M+12.1%

Total equity$2.4M-97.4%

Total assets$782.4M-9.1%

Cash flow

See full

Operating cash flow-$44.7M-1.4%

CapEx$3.0M+119%

Free cash flow-$47.7M-5.0%

Valuation

See full

Market cap$496.96M+30.4%

Enterprise value$498.38M+33.5%

P/S3.1×+0.6×

Profitability

See full

Gross margin37.5%+21.3pp

Operating margin-83.3%-38.2pp

Net margin-80.3%-36.1pp

FCF margin-72.6%-20.0pp

Returns & leverage

See full

Return on equity-273.6%+314pp

Debt / equity25.1×+24.5×

Current ratio5.7×-1.0×

Where this comes from

Reported directly by Pacific Biosciences of California in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue.

The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacific Biosciences of California's available-for-sale debt securities - fair value (maturing within 1 year).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pacific Biosciences of California's available-for-sale debt securities - fair value (maturing within 1 year)?: Pacific Biosciences of California (PACB) reported available-for-sale debt securities - fair value (maturing within 1 year) of $136.54M in Q1 2026.
How has Pacific Biosciences of California's available-for-sale debt securities - fair value (maturing within 1 year) changed year-over-year?: Pacific Biosciences of California's available-for-sale debt securities - fair value (maturing within 1 year) decreased by 40.0% year-over-year, from $227.68M to $136.54M.